A detailed history of Pnc Financial Services Group, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 79 shares of RLAY stock, worth $379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 79 -0.0%
Holding current value
$379
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$5.9 - $8.02 $985 - $1,339
-167 Reduced 67.89%
79 $0
Q1 2024

May 10, 2024

BUY
$7.5 - $12.07 $1,500 - $2,414
200 Added 434.78%
246 $2,000
Q4 2023

Feb 09, 2024

BUY
$6.01 - $11.48 $276 - $528
46 New
46 $0
Q3 2022

Nov 10, 2022

BUY
$18.07 - $31.37 $108 - $188
6 New
6 $0

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $577M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.